{"uuid": "d1ed53ab-c91c-4892-8b6d-ca7a61b1efad", "tweet_id": "1337330354617724931", "replies": [], "reply_to": "1337330352935882753", "avatar": "https://pbs.twimg.com/profile_images/1356520420686655490/zgNB3Ir9_normal.jpg", "user_handle": "sputnikvaccine", "user_name": "Sputnik V", "content": "Kirill Dmitriev, RDIF CEO: #SputnikV is showing high efficacy itself and can also be combined with other vaccines. Gamaleya and RDIF welcome joint clinical trial with @AstraZeneca to explore adding #SputnikV human adenoviral vector to AZ vaccine.\nAstraZeneca will test using component of Russia\u2019s Sputnik V in clinical trials of its own vaccine...sputnikvaccine.com", "date": "5:36 PM \u00b7 Dec 11, 2020\u00b7Twitter Web App", "engagement": "22 Retweets7 Quote Tweets54 Likes", "avatar_extension": "jpg"}